2.3 Million Cancer Cases Worldwide Linked to Viral, Bacterial Infections: Lancet Oncology Study
A Lancet Oncology study estimates that 2.3 million cancer cases globally in 2024 were linked to infections, with HPV and hepatitis B being significant contributors. In India, HPV accounted for about 100,000 cases.
What Happened?
A Lancet Oncology study estimates that 2.3 million cancer cases globally in 2024 were linked to infections, with HPV and hepatitis B being significant contributors. In India, HPV accounted for about 100,000 cases.
AI Quick Summary
A study links 2.3 million cancer cases in 2024 to infections, with HPV and hepatitis B as major contributors.
Key points
- 2.3 million new cancer cases in 2024 were linked to infections, accounting for 12% of all cases.
- The leading causes include H pylori (760,000 cases), HPV (750,000), and hepatitis B (360,000).
- Low-income countries accounted for 77% of infection-attributable cancer cases.
- India had about 100,000 HPV-attributable cancer cases, representing 77% of such cases in south-central Asia.
- The WHO's strategy for cervical cancer elimination focuses on high-risk HPV vaccination.
Key insights
- Targeting HPV through vaccination could significantly reduce cervical cancer rates.
- Increased awareness and access to vaccinations may improve health outcomes in low-income regions.
- Addressing societal and financial barriers is crucial for effective cancer prevention strategies.
Why it matters
The findings highlight the significant role of infections in cancer cases, emphasizing the need for vaccination and preventive measures.
Source
Times Now
